1. Home
  2. BDL vs ONCY Comparison

BDL vs ONCY Comparison

Compare BDL & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$46.29

Market Cap

84.6M

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

N/A

Current Price

$0.56

Market Cap

80.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BDL
ONCY
Founded
1959
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
80.5M
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
BDL
ONCY
Price
$46.29
$0.56
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $4.14
AVG Volume (30 Days)
21.4K
★ 1.0M
Earning Date
08-12-2026
11-11-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
N/A
N/A
EPS
★ 3.09
N/A
Revenue
★ $205,248,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.01
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.55
$0.54
52 Week High
$52.12
$1.32

Technical Indicators

Market Signals
Indicator
BDL
ONCY
Relative Strength Index (RSI) 54.14 22.95
Support Level $29.36 N/A
Resistance Level $47.99 $0.89
Average True Range (ATR) 1.91 0.04
MACD 0.16 -0.01
Stochastic Oscillator 73.78 12.50

Price Performance

Historical Comparison
BDL
ONCY

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: